Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 500 participants.

Also called NCT02601781

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 500 participants (enrolled count) (from the registry)
Sponsor
Azienda Ospedaliera Bolognini di Seriate Bergamo (from the registry)
Registry
  • NCT NCT02601781
Other papers using this trial's data
  • Five-year clinical outcomes of STEMI patients treated with a pre-specified bioresorbable vascular scaffold implantation technique: Final results of the BVS STEMI STRATEGY-IT Cardiovascular revascularization medicine : including molecular interventions, 2025-09 DOI, PubMed 39547832

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02601781. Allocation not applicable; no masking; primary purpose treatment. Start 2015-10 (registry gives no type); primary completion 2016-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry
Acronym
STRATEGY-IT
Condition
ST-elevation Myocardial Infarction (STEMI)
Intervention (Procedure)
Primary percutaneous coronary intervention (PPCI)
Intervention (Device)
Bioresorbable Vascular Scaffold (BVS ABSORB)
Lead sponsor
Azienda Ospedaliera Bolognini di Seriate Bergamo (class: other)

Record details

Record id
cardio:ct-nct02601781
Content hash
40c801b16d33aea0fa6780edd0567092124915440f3553bda3ff9e3dbede5450